Recovery of spaceflight-induced bone loss: Bone mineral density after long-duration missions as fitted with an exponential function

NASA, Вашингтон, West Virginia, United States
Bone (Impact Factor: 3.97). 01/2008; 41(6):973-8. DOI: 10.1016/j.bone.2007.08.022
Source: PubMed

ABSTRACT

The loss of bone mineral in NASA astronauts during spaceflight has been investigated throughout the more than 40 years of space travel. Consequently, it is a medical requirement at NASA Johnson Space Center (JSC) that changes in bone mass be monitored in crew members by measuring bone mineral density (BMD), with dual-energy X-ray absorptiometry (DXA) before and after flight, of astronauts who serve on long-duration missions (4-6 months). We evaluated this repository of medical data to track whether there is recovery of bone mineral that was lost during spaceflight. Our analysis was supplemented by BMD data from cosmonauts (by convention, a space traveler formally employed by the Russia Aviation and Space Agency or by the previous Soviet Union) who had also flown on long-duration missions. Data from a total of 45 individual crew members - a small number of whom flew on more than one mission - were used in this analysis. Changes in BMD (between 56 different sets of pre- and postflight measurements) were plotted as a function of time (days after landing). Plotted BMD changes were fitted to an exponential mathematical function that estimated: (i) BMD change on landing day (day 0) and (ii) the number of days after landing when 50% of the lost bone would be recovered ("50% recovery time") in the lumbar spine, trochanter, pelvis, femoral neck and calcaneus. In sum, averaged losses of bone mineral after long-duration spaceflight ranged between 2% and 9% across all sites with our recovery model predicting a 50% restoration of bone loss for all sites to be within 9 months.

Download full-text

Full-text

Available from: Thomas Lang
    • "Peripheral quantitative computed tomography (CT) analysis of distal tibia in astronauts aft er six months of spacefl ights showed up to 24% of trabecular bone lost and aft er six months from the return on Earth the recovery of bone mineral density (BMD) was not complete (Vico et al. 2000). Indeed, the recovery of skeletal density aft er long-duration space missions was estimated to exceed one year (Sibonga et al. 2007). Th ese data have suggested that i) mechanical stress, as that induced by Earth's gravity, was a crucial underlying factor for normal bone homeostasis; ii) exposure to weightlessness was a causal factor of osteoporosis; iii) the loss of bone mass was more quick in astronauts than postmenopausal women; and iv) the severity of osteoporosis was proportional to the length of exposure to microgravity (Vogel 1975; Hughes-Fulford 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Osteoporosis is one of the established major consequences of long-duration spaceflights in astronauts seriously undermining their health after their returning on Earth. Indeed, astronauts typically lose more bone mass during one month than postmenopausal women on Earth lose in one year. To date, countermeasures mainly consist in exercise and supplementation while pharmacological treatment as those used in postmenopausal women are not routine. However, it is evident that exercise and supplementation alone are not enough to maintain bone homeostasis. In this paper we describe the current countermeasures for bone loss during long-term spaceflight, review the modern treatment which are successfully employed to prevent osteoporosis on Earth and that could be quickly used also for astronauts and finally focus on the recent cellular and molecular understanding of bone homeostasis which might provide the basis for the development of future targeted therapies.
    No preview · Article · Oct 2015 · Endocrine regulations
  • Source
    • "As previously described (Smith et al. 2005b, 2008; Sibonga et al. 2007), areal bone mineral density (BMD) scans for both the UCSD and UTMB bed rest studies were performed by dual-energy X-ray absorptiometry (DXA) using either a Hologic QDR 450 or Hologic Discovery instrument (Hologic, Bedford, MA) at UTMB (Spector et al. 2009), or a Hologic Delphi W or Lunar DPX-IQ instrument at UCSD (Zwart et al. 2007). Scans were performed 8–13 days before bed rest and again 1–2 days after bed rest, only on the subjects who participated in the 30-day study at UCSD and the 60- and 90-day studies at UTMB. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to directly assess sex differences in bone loss, bone biochemistry, and renal stone risk in bed rest. Bed rest simulates some spaceflight effects on human physiology and can be used to address the potential existence of sex-specific effects on bone metabolism and renal stone risk in space. We combined data from the control subjects in five head-down-tilt bed rest studies (combined n = 50 men, 24 women) of differing durations (14–90 days). All subjects were healthy volunteers. Mean age was 35 ± 9 years for women and 33 ± 8 years for men. The main outcome measures were bone density and biochemistry, and renal stone risk chemistry. Before bed rest began, men had higher bone mineral density and content (P < 0.001), and excreted more biomarkers of bone resorption and calcium per day than did women (P < 0.05). These differences remained during bed rest. A number of urine chemistry analytes increased (e.g., calcium) or decreased (e.g., sodium, citrate, and urine volume) significantly for men and women during bed rest. These changes may predispose men to higher stone risk. Men and women do not have substantially different responses to the skeletal unloading of bed rest.
    Full-text · Article · Aug 2014
  • Source
    • "For example, the loss of bone in μg is about 10 times greater than the bone mineral density loss per month of postmenopausal women on Earth, who are not on estrogen therapy [132–135]. The loss of bone mineral density in a six-month mission appeared to be reversible in 1000 days after return to Earth [136, 137], but changes in the bone structure are irreversible and seem to mimic changes in the elderly [137]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: How microgravity affects the biology of human cells and the formation of 3D cell cultures in real and simulated microgravity (r- and s-µg) is currently a hot topic in biomedicine. In r- and s-µg, various cell types were found to form 3D structures. This review will focus on the current knowledge of tissue engineering in space and on Earth using systems such as the random positioning machine (RPM), the 2D-clinostat, or the NASA-developed rotating wall vessel bioreactor (RWV) to create tissue from bone, tumor, and mesenchymal stem cells. To understand the development of 3D structures, in vitro experiments using s-µg devices can provide valuable information about modulations in signal-transduction, cell adhesion, or extracellular matrix induced by altered gravity conditions. These systems also facilitate the analysis of the impact of growth factors, hormones, or drugs on these tissue-like constructs. Progress has been made in bone tissue engineering using the RWV, and multicellular tumor spheroids (MCTS), formed in both r- and s-µg, have been reported and were analyzed in depth. Currently, these MCTS are available for drug testing and proteomic investigations. This review provides an overview of the influence of µg on the aforementioned cells and an outlook for future perspectives in tissue engineering.
    Full-text · Article · Jul 2014 · BioMed Research International
Show more